within Pharmacolibrary.Drugs.ATC.R;

model R06AA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 5.833333333333333e-06,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AA08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Carbinoxamine is a first-generation antihistamine used in the treatment of allergic conditions such as hay fever, urticaria, and allergic rhinitis. It is also sometimes used to relieve symptoms of the common cold. Carbinoxamine works by blocking H1 histamine receptors. Its use has become less common due to the sedative effects, but it is still available and approved in some countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals. No published human population pharmacokinetic studies found.</p><h4>References</h4><ol><li><p>Li, P, et al., &amp; Li, Q (2018). Development and full validation of a liquid chromatography-tandem mass spectrometry method for determination of carbinoxamine in beagle plasma and its application to a pharmacokinetic study. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 1093-1094 183–189. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2018.05.002&quot;>10.1016/j.jchromb.2018.05.002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30032018/&quot;>https://pubmed.ncbi.nlm.nih.gov/30032018</a></p></li><li><p>El-Masry, SM, &amp; El-Morsi, RM (2019). Simple HPLC Method for Quantitative Determination of Carbinoxamine in Human Plasma: Application in Pharmacokinetic Studies and Therapeutic Drug Monitoring. <i>Drug research</i> 69(6) 342–347. DOI:<a href=&quot;https://doi.org/10.1055/a-0787-1302&quot;>10.1055/a-0787-1302</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30658353/&quot;>https://pubmed.ncbi.nlm.nih.gov/30658353</a></p></li><li><p>Liu, Y, et al., &amp; Xu, B (2018). A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate. <i>Drug development and industrial pharmacy</i> 44(8) 1317–1327. DOI:<a href=&quot;https://doi.org/10.1080/03639045.2018.1449854&quot;>10.1080/03639045.2018.1449854</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29521132/&quot;>https://pubmed.ncbi.nlm.nih.gov/29521132</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AA08;
